mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor MicroenvironmentMichael Haas(Ensemble Therapeutics (United States)), Walter Newman(Ensemble Therapeutics (United States))Molecular Cancer ResearchDecember 22, 202010.1158/1541-7786.mcr-20-0799Cited by 69SaveCiteExport RISWatch citationsRelated PapersSrc-mediated Inter-receptor Cross-talk between the Na+/K+-ATPase and the Epidermal Growth Factor Receptor Relays the Signal from Ouabain to Mitogen-activated Protein Kinases|Journal of Biological Chemistry|2002|296